Elevated HbA1c is Associated with Increased Risk of Incident Dementia in Primary Care Patients

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Alzheimer's Disease

• Publication date

  2015-02-19

• Fields of study

  Medicine

• Identifiers
  DOI 10.3233/JAD-141521PMID 25524954
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metabolic Syndrome and Longitudinal Changes in Cognitive Function: A Systematic Review and Meta-Analysis

  2014cited by this paper
• Inflammation, Defective Insulin Signaling, and Mitochondrial Dysfunction as Common Molecular Denominators Connecting Type 2 Diabetes to Alzheimer Disease

  2014cited by this paper
• Glucose levels and risk of dementia.

  2013cited by this paper
• Association between hypoglycemia and dementia in a biracial cohort of older adults with diabetes mellitus.

  2013cited by this paper
• Diabetes, hyperglycaemia, and acute ischaemic stroke.

  2012cited by this paper
• An update on type 2 diabetes, vascular dementia and Alzheimer's disease.

  2012cited by this paper
• Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach

  2012cited by this paper
• Standards of Medical Care in Diabetes—2013

  2012cited by this paper
• Poor Cognitive Function and Risk of Severe Hypoglycemia in Type 2 Diabetes

  2012cited by this paper
• Metabolic Syndrome, Diabetes, Poor Cognition, and Dementia in the Caerphilly Prospective Study

  2012cited by this paper
• Brain Insulin Resistance and Deficiency as Therapeutic Targets in Alzheimer's Disease

  2012cited by this paper
• Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia.

  2012cited by this paper
• Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

  2012cited by this paper
• Brain Insulin Resistance and Deficiency as Therapeutic Targets in Alzheimer's Disease

  2012cited by this paper
• Incidence of Dementia is Increased in Type 2 Diabetes and Reduced by the Use of Sulfonylureas and Metformin

  2011cited by this paper
• Metabolic syndrome, mild cognitive impairment, and progression to dementia. The Italian Longitudinal Study on Aging.

  2011cited by this paper
• Prediction of Dementia in Primary Care Patients

  2011cited by this paper
• Cognitive function, dementia and type 2 diabetes mellitus in the elderly

  2011cited by this paper
• Glycated haemoglobin and cognitive decline: the Atherosclerosis Risk in Communities (ARIC) study

  2011cited by this paper
• Changes in Glycemic Control are Associated with Changes in Cognition in Non-Diabetic Elderly

  2011cited by this paper
• Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

  2011cited by this paper
• Frailty syndrome and the risk of vascular dementia: The Italian Longitudinal Study on Aging

  2010cited by this paper
• Diabetes Medications Related to an Increased Risk of Falls and Fall-Related Morbidity in the Elderly

  2010cited by this paper
• Metabolic Syndrome and Risk for Incident Alzheimer's Disease or Vascular Dementia

  2009cited by this paper
• Uncontrolled diabetes increases the risk of Alzheimer’s disease: a population-based cohort study

  2009cited by this paper
• Redefining the Diagnosis of Diabetes Using Glycated Hemoglobin

  2009cited by this paper
• International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes

  2009cited by this paper
• Metabolic syndrome and the risk of vascular dementia: the Italian Longitudinal Study on Ageing

  2009cited by this paper
• Predictors of cognitive impairment and dementia in older people with diabetes

  2008cited by this paper
• Effects of intensive glucose lowering in type 2 diabetes.

  2008cited by this paper
• An investigation of the population impact of variation in HbA1c levels in older people in England and Wales: From a population based multi-centre longitudinal study

  2008cited by this paper
• Cognitive dysfunction and diabetes mellitus.

  2008cited by this paper
• Mild Cognitive Impairment in General Practice: Age-Specific Prevalence and Correlate Results from the German Study on Ageing, Cognition and Dementia in Primary Care Patients (AgeCoDe)

  2007cited by this paper
• The Effect of Borderline Diabetes on the Risk of Dementia and Alzheimer’s Disease

  2007cited by this paper
• Metabolic Syndrome and Dementia Risk in a Multiethnic Elderly Cohort

  2007cited by this paper
• Risk of dementia in diabetes mellitus: a systematic review.

  2006cited by this paper
• Glycosylated hemoglobin level and development of mild cognitive impairment or dementia in older women.

  2006cited by this paper
• Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: review and hypothesis.

  2006cited by this paper
• Risk factors for progression of brain atrophy in aging

  2005cited by this paper
• Change in body mass index and risk of incident Alzheimer disease

  2005cited by this paper
• Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study.

  2002cited by this paper
• Dementia and Alzheimer disease incidence: a prospective cohort study.

  2002cited by this paper
• Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group.

  2000cited by this paper
• Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group.

  2000cited by this paper
• Vascular dementia

  1993cited by this paper
• SIDAM – A Structured Interview for the diagnosis of Dementia of the Alzheimer type, Multi-infarct dementia and dementias of other aetiology according to ICD-10 and DSM-III-R

  1991cited by this paper
• Geriatric Depression Scale (GDS): Recent evidence and development of a shorter version.

  1986cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper
• The Global Deterioration Scale for assessment of primary degenerative dementia.

  1982cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper
• The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly Subjects

  1968cited by this paper

• Current and Emerging Therapeutic Approaches for Vascular Cognitive Impairment and Dementia.

  2026cites this paper
• Estimating the Clinical, Quality-of-Life and Economic Impact of Optimized Management of Type 2 Diabetes Patients in Spain.

  2026cites this paper
• Vascular cognitive impairment and dementia: Prevention, treatments, mechanisms and management options for the future.

  2026cites this paper
• Review of Associations of Diabetes and Insulin Resistance With Brain Health in Three Harmonised Cohort Studies of Ageing and Dementia

  2025cites this paper
• Increased Brain Activity Associated With Improved Metabolic Biomarkers: A Case Series

  2025cites this paper
• Glycated hemoglobin and body mass index as mediators of GLP‐1RAs and Alzheimer's disease and related dementias in patients with type 2 diabetes

  2025cites this paper
• Association of late‐life variability in hemoglobin A1C with postmortem neuropathologies

  2025cites this paper
• Ketosis Suppression and Ageing (KetoSAge) Part 2: The Effect of Suppressing Ketosis on Biomarkers Associated with Ageing, HOMA-IR, Leptin, Osteocalcin, and GLP-1, in Healthy Females

  2024influential citation
• Effects of glycaemic control on memory performance, hippocampal volumes and depressive symptomology

  2024cites this paper
• Development, validation and application of an LC–MS/MS method quantifying free forms of the micronutrients queuine and queuosine in human plasma using a surrogate matrix approach

  2024cites this paper
• Risk of Dementia Among Patients With Diabetes in a Multidisciplinary, Primary Care Management Program

  2024cites this paper
• Ceramides are Fuel Gauges on the Drive to Cardiometabolic Disease.

  2024cites this paper
• An Investigation into the Relationship of Circulating Gut Microbiome Molecules and Inflammatory Markers with the Risk of Incident Dementia in Later Life

  2023cites this paper
• The effects of long-term cumulative HbA1c exposure on the development and onset time of dementia in the patients with type 2 diabetes mellitus: hospital based retrospective study (2005-2021).

  2023cites this paper
• Nicotinamide as potential biomarker for Alzheimer’s disease: A translational study based on metabolomics

  2023cites this paper
• Medical Journey of Patients with Mild Cognitive Impairment and Mild Alzheimer’s Disease Dementia: A Cross-sectional Survey of Patients, Care Partners, and Neurologists

  2023cites this paper
• Hemoglobin A1c Serum Level Predicts 5-year Mortality in Patients with Cognitive Impairment

  2023cites this paper
• Early Cognitive Decline Assessment via the Synergy of Machine Learning Algorithms and Cognitive Proficiency Examination

  2023cites this paper
• Early Detection of Cognitive Decline Using Machine Learning Algorithm and Cognitive Ability Test

  2022cites this paper
• The Correlation between Diabetes Mellitus and Neurodegenerative Diseases

  2022influential citation
• The neurocognitive disorder cohort RIFADE: Aims, methods, first results showing cognitive improvement in a subgroup

  2022cites this paper
• Associations between abdominal adipose tissue, reproductive span, and brain characteristics in post-menopausal women

  2022cites this paper
• Saffron as a promising therapy for diabetes and Alzheimer's disease: mechanistic insights

  2022cites this paper
• Hip Fracture as a Predictive Marker for the Risk of Dementia: A Population-Based Cohort Study.

  2022cites this paper
• Prediabetes and the incidence of dementia in general population: a systematic review and meta‐analysis of prospective studies

  2022cites this paper
• Eight-week exercise program improved the quality of life of Alzheimer’s patients through functional, cognitive, and biochemical parameters

  2022cites this paper
• Glucose-lowering drugs, cognition, and dementia: the clinical evidence.

  2022cites this paper
• High sensitivity C-reactive protein and glycated hemoglobin levels as dominant predictors of all-cause dementia: a nationwide population-based cohort study

  2022cites this paper
• Feasibility and preliminary efficacy of the LEAD trial: a cluster randomized controlled lifestyle intervention to improve hippocampal volume in older adults at-risk for dementia

  2022cites this paper
• Type 2 Diabetes, Glycemic Control, and Their Association With Dementia and Its Major Subtypes: Findings From the Swedish National Diabetes Register.

  2022cites this paper
• Primary prevention recommendations to reduce the risk of cognitive decline

  2022cites this paper
• Neurocognitive dysfunction among type 2 diabetes patients attending primary health care in Jeddah, Saudi Arabia

  2021cites this paper
• Nicotinamide as potential biomarker for Alzheimer’s disease: a translational study based on metabolomics

  2021cites this paper
• Self‐reported regular daytime napping is associated with indicators of poor type 2 diabetes control: A cohort study

  2021cites this paper
• Antidiabetic Drugs for the Risk of Alzheimer Disease in Patients With Type 2 DM Using FAERS

  2020cites this paper
• Lifestyle intervention to prevent Alzheimer’s disease

  2020cites this paper
• Insulin resistance: a connecting link between Alzheimer’s disease and metabolic disorder

  2020cites this paper
• Personality and HbA1c: Findings from six samples.

  2020cites this paper
• Methylomic profiling in trisomy 21 identifies cognition- and Alzheimer’s disease-related dysregulation

  2019cites this paper
• Alzheimer’s disease-associated (hydroxy)methylomic changes in the brain and blood

  2019cites this paper
• Higher dementia incidence in older adults with type 2 diabetes and large reduction in HbA1c.

  2019cites this paper
• Risk of dementia and cognitive dysfunction in individuals with diabetes or elevated blood glucose

  2019cites this paper
• Computerized cognitive training for older adults at higher dementia risk due to diabetes: findings from a randomized controlled trial.

  2019cites this paper
• Investigation of the Effects of Biochemical Parameters on Alzheimer’s Disease

  2019cites this paper
• Non-Pharmacological Interventions for Cognition in Patients with Type 2 Diabetes Mellitus: A Systematic Review.

  2019cites this paper
• Depression in type 1 diabetes and risk of dementia

  2019influential citation
• [Diabetes mellitus and cognitive impairment].

  2019cites this paper
• Long-term Glycemic Control and Dementia Risk in Type 1 Diabetes

  2018cites this paper
• Obesity as a risk factor for Alzheimer's disease: weighing the evidence

  2018cites this paper
• Biomarkers associated with glycaemic control, comorbidity and response to GLP-1 analogue therapy

  2018cites this paper
• Building an allostatic load index from data of occupational medical checkup examinations: a feasibility study

  2018cites this paper
• Association Between the Use of Antihyperglycemic Drugs and Dementia Risk: A Case-Control Study

  2018cites this paper
• Cognitive function in early and later life is associated with blood glucose in older individuals: analysis of the Lothian Birth Cohort of 1936

  2018cites this paper
• Visit-to-Visit Variations in Fasting Plasma Glucose and HbA1c Associated With an Increased Risk of Alzheimer Disease: Taiwan Diabetes Study

  2017cites this paper
• lycemic control and health-related quality of life mong older home-dwelling primary care patients ith diabetes

  2017cites this paper
• Diabetes, Hemoglobin A1C, and Regional Alzheimer Disease and Infarct Pathology

  2017cites this paper
• Kidney, heart and brain: three organs targeted by ageing and glycation.

  2017cites this paper
• Glycemic control and health-related quality of life among older home-dwelling primary care patients with diabetes.

  2017cites this paper
• Ameliorating effect of anti-Alzheimer’s drugs on the bidirectional association between type 2 diabetes mellitus and Alzheimer’s disease

  2017cites this paper
• Alternative Measures of Hyperglycemia and Risk of Alzheimer’s Disease in the Community: The Hisayama Study

  2017cites this paper
• Consequences of delaying treatment intensification in type 2 diabetes: evidence from a UK database

  2016cites this paper
• ACCORDION MIND: results of the observational extension of the ACCORD MIND randomised trial

  2016cites this paper
• Therapeutic Potential of Antidiabetic Medications in the Treatment of Cognitive Dysfunction and Dementia

  2016cites this paper
• The Swedish National Diabetes Register in clinical practice and evaluation in primary health care

  2016cites this paper
• Complex mechanisms linking neurocognitive dysfunction to insulin resistance and other metabolic dysfunction

  2016cites this paper
• [Diabetes mellitus and dementia].

  2015cites this paper
• The Role of Diet, Physical Activity, and Lifestyle in Alzheimer's Disease Prevention: A

  year unknowninfluential citation